nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—stomach cancer	0.178	0.529	CbGaD
Etodolac—ALB—stomach cancer	0.159	0.471	CbGaD
Etodolac—UGT1A9—Irinotecan—stomach cancer	0.102	0.297	CbGbCtD
Etodolac—UGT2B7—Epirubicin—stomach cancer	0.0996	0.289	CbGbCtD
Etodolac—ALB—Irinotecan—stomach cancer	0.0318	0.0921	CbGbCtD
Etodolac—ALB—Fluorouracil—stomach cancer	0.0305	0.0883	CbGbCtD
Etodolac—CYP2C9—Capecitabine—stomach cancer	0.0277	0.0803	CbGbCtD
Etodolac—SLC22A6—Methotrexate—stomach cancer	0.0197	0.0572	CbGbCtD
Etodolac—ALB—Methotrexate—stomach cancer	0.0168	0.0487	CbGbCtD
Etodolac—CYP2C9—Fluorouracil—stomach cancer	0.0164	0.0476	CbGbCtD
Etodolac—UGT1A10—digestive system—stomach cancer	0.00316	0.0814	CbGeAlD
Etodolac—UGT1A10—endocrine gland—stomach cancer	0.00261	0.0673	CbGeAlD
Etodolac—UGT1A10—liver—stomach cancer	0.00236	0.0606	CbGeAlD
Etodolac—UGT1A3—digestive system—stomach cancer	0.00223	0.0574	CbGeAlD
Etodolac—ALB—gall bladder—stomach cancer	0.00186	0.0479	CbGeAlD
Etodolac—UGT1A3—endocrine gland—stomach cancer	0.00184	0.0474	CbGeAlD
Etodolac—UGT1A3—liver—stomach cancer	0.00166	0.0427	CbGeAlD
Etodolac—UGT1A9—digestive system—stomach cancer	0.00159	0.0409	CbGeAlD
Etodolac—RXRA—endocrine gland—stomach cancer	0.00156	0.0401	CbGeAlD
Etodolac—RXRA—liver—stomach cancer	0.00141	0.0362	CbGeAlD
Etodolac—UGT1A9—endocrine gland—stomach cancer	0.00131	0.0338	CbGeAlD
Etodolac—UGT2B7—digestive system—stomach cancer	0.00128	0.0329	CbGeAlD
Etodolac—UGT1A9—liver—stomach cancer	0.00118	0.0304	CbGeAlD
Etodolac—PTGS1—blood vessel—stomach cancer	0.00113	0.029	CbGeAlD
Etodolac—PTGS2—blood vessel—stomach cancer	0.00108	0.0277	CbGeAlD
Etodolac—UGT2B7—endocrine gland—stomach cancer	0.00106	0.0272	CbGeAlD
Etodolac—PTGS2—gall bladder—stomach cancer	0.00101	0.0261	CbGeAlD
Etodolac—UGT2B7—liver—stomach cancer	0.000954	0.0245	CbGeAlD
Etodolac—CYP2C9—hematopoietic system—stomach cancer	0.000658	0.0169	CbGeAlD
Etodolac—PTGS1—hematopoietic system—stomach cancer	0.000601	0.0155	CbGeAlD
Etodolac—PTGS2—hematopoietic system—stomach cancer	0.000574	0.0148	CbGeAlD
Etodolac—PTGS1—epithelium—stomach cancer	0.000549	0.0141	CbGeAlD
Etodolac—ALB—liver—stomach cancer	0.000546	0.014	CbGeAlD
Etodolac—PTGS1—smooth muscle tissue—stomach cancer	0.000529	0.0136	CbGeAlD
Etodolac—PTGS2—epithelium—stomach cancer	0.000525	0.0135	CbGeAlD
Etodolac—PTGS2—smooth muscle tissue—stomach cancer	0.000506	0.013	CbGeAlD
Etodolac—PTGS2—pancreas—stomach cancer	0.000468	0.012	CbGeAlD
Etodolac—CYP2C9—digestive system—stomach cancer	0.000458	0.0118	CbGeAlD
Etodolac—ALB—lymph node—stomach cancer	0.000419	0.0108	CbGeAlD
Etodolac—PTGS1—digestive system—stomach cancer	0.000418	0.0107	CbGeAlD
Etodolac—PTGS2—lymphoid tissue—stomach cancer	0.000404	0.0104	CbGeAlD
Etodolac—PTGS2—digestive system—stomach cancer	0.000399	0.0103	CbGeAlD
Etodolac—CYP2C9—endocrine gland—stomach cancer	0.000378	0.00973	CbGeAlD
Etodolac—PTGS2—bone marrow—stomach cancer	0.000368	0.00947	CbGeAlD
Etodolac—PTGS1—endocrine gland—stomach cancer	0.000345	0.00888	CbGeAlD
Etodolac—CYP2C9—liver—stomach cancer	0.000341	0.00877	CbGeAlD
Etodolac—PTGS2—endocrine gland—stomach cancer	0.00033	0.00849	CbGeAlD
Etodolac—PTGS2—liver—stomach cancer	0.000297	0.00765	CbGeAlD
Etodolac—PTGS1—lymph node—stomach cancer	0.000239	0.00614	CbGeAlD
Etodolac—PTGS2—lymph node—stomach cancer	0.000228	0.00587	CbGeAlD
Etodolac—Shock—Capecitabine—stomach cancer	0.000112	0.000663	CcSEcCtD
Etodolac—Rhinitis—Epirubicin—stomach cancer	0.000112	0.000663	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—stomach cancer	0.000112	0.000662	CcSEcCtD
Etodolac—Haemorrhage—Epirubicin—stomach cancer	0.000112	0.000661	CcSEcCtD
Etodolac—Hepatitis—Epirubicin—stomach cancer	0.000112	0.000661	CcSEcCtD
Etodolac—Diarrhoea—Fluorouracil—stomach cancer	0.000112	0.00066	CcSEcCtD
Etodolac—Thrombocytopenia—Capecitabine—stomach cancer	0.000112	0.00066	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—stomach cancer	0.000111	0.000659	CcSEcCtD
Etodolac—Tachycardia—Capecitabine—stomach cancer	0.000111	0.000658	CcSEcCtD
Etodolac—Pharyngitis—Epirubicin—stomach cancer	0.000111	0.000656	CcSEcCtD
Etodolac—Sweating—Doxorubicin—stomach cancer	0.00011	0.000653	CcSEcCtD
Etodolac—Hyperhidrosis—Capecitabine—stomach cancer	0.00011	0.000652	CcSEcCtD
Etodolac—Hypotension—Docetaxel—stomach cancer	0.00011	0.000651	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—stomach cancer	0.00011	0.00065	CcSEcCtD
Etodolac—Anorexia—Capecitabine—stomach cancer	0.000109	0.000643	CcSEcCtD
Etodolac—Vomiting—Irinotecan—stomach cancer	0.000108	0.00064	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—stomach cancer	0.000108	0.000639	CcSEcCtD
Etodolac—Dizziness—Fluorouracil—stomach cancer	0.000108	0.000638	CcSEcCtD
Etodolac—Visual impairment—Epirubicin—stomach cancer	0.000108	0.000637	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—stomach cancer	0.000107	0.000636	CcSEcCtD
Etodolac—Rash—Irinotecan—stomach cancer	0.000107	0.000635	CcSEcCtD
Etodolac—Dermatitis—Irinotecan—stomach cancer	0.000107	0.000634	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000107	0.000634	CcSEcCtD
Etodolac—Chills—Methotrexate—stomach cancer	0.000107	0.000634	CcSEcCtD
Etodolac—Headache—Irinotecan—stomach cancer	0.000107	0.000631	CcSEcCtD
Etodolac—Hypotension—Capecitabine—stomach cancer	0.000106	0.00063	CcSEcCtD
Etodolac—Insomnia—Docetaxel—stomach cancer	0.000106	0.00063	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—stomach cancer	0.000106	0.000625	CcSEcCtD
Etodolac—Erythema multiforme—Epirubicin—stomach cancer	0.000106	0.000625	CcSEcCtD
Etodolac—Alopecia—Methotrexate—stomach cancer	0.000106	0.000624	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—stomach cancer	0.000105	0.000621	CcSEcCtD
Etodolac—Somnolence—Docetaxel—stomach cancer	0.000105	0.000619	CcSEcCtD
Etodolac—Tinnitus—Epirubicin—stomach cancer	0.000104	0.000616	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—stomach cancer	0.000104	0.000615	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000104	0.000614	CcSEcCtD
Etodolac—Flushing—Epirubicin—stomach cancer	0.000104	0.000613	CcSEcCtD
Etodolac—Vomiting—Fluorouracil—stomach cancer	0.000104	0.000613	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—stomach cancer	0.000104	0.000613	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—stomach cancer	0.000104	0.000613	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—stomach cancer	0.000103	0.000612	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—stomach cancer	0.000103	0.000612	CcSEcCtD
Etodolac—Insomnia—Capecitabine—stomach cancer	0.000103	0.00061	CcSEcCtD
Etodolac—Rash—Fluorouracil—stomach cancer	0.000103	0.000608	CcSEcCtD
Etodolac—Dermatitis—Fluorouracil—stomach cancer	0.000103	0.000608	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—stomach cancer	0.000103	0.000607	CcSEcCtD
Etodolac—Paraesthesia—Capecitabine—stomach cancer	0.000102	0.000605	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—stomach cancer	0.000102	0.000605	CcSEcCtD
Etodolac—Headache—Fluorouracil—stomach cancer	0.000102	0.000604	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—stomach cancer	0.000102	0.000602	CcSEcCtD
Etodolac—Dyspnoea—Capecitabine—stomach cancer	0.000102	0.000601	CcSEcCtD
Etodolac—Fatigue—Docetaxel—stomach cancer	0.000101	0.0006	CcSEcCtD
Etodolac—Nausea—Irinotecan—stomach cancer	0.000101	0.000598	CcSEcCtD
Etodolac—Pain—Docetaxel—stomach cancer	0.000101	0.000595	CcSEcCtD
Etodolac—Constipation—Docetaxel—stomach cancer	0.000101	0.000595	CcSEcCtD
Etodolac—Dyspepsia—Capecitabine—stomach cancer	0.0001	0.000593	CcSEcCtD
Etodolac—Chills—Epirubicin—stomach cancer	0.0001	0.000593	CcSEcCtD
Etodolac—Arrhythmia—Epirubicin—stomach cancer	9.98e-05	0.00059	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—stomach cancer	9.96e-05	0.000589	CcSEcCtD
Etodolac—Decreased appetite—Capecitabine—stomach cancer	9.91e-05	0.000586	CcSEcCtD
Etodolac—Alopecia—Epirubicin—stomach cancer	9.87e-05	0.000584	CcSEcCtD
Etodolac—Fatigue—Capecitabine—stomach cancer	9.83e-05	0.000581	CcSEcCtD
Etodolac—Vision blurred—Methotrexate—stomach cancer	9.8e-05	0.000579	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—stomach cancer	9.78e-05	0.000578	CcSEcCtD
Etodolac—Constipation—Capecitabine—stomach cancer	9.75e-05	0.000576	CcSEcCtD
Etodolac—Pain—Capecitabine—stomach cancer	9.75e-05	0.000576	CcSEcCtD
Etodolac—Feeling abnormal—Docetaxel—stomach cancer	9.7e-05	0.000574	CcSEcCtD
Etodolac—Nausea—Fluorouracil—stomach cancer	9.69e-05	0.000573	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—stomach cancer	9.64e-05	0.00057	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—stomach cancer	9.64e-05	0.00057	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—stomach cancer	9.62e-05	0.000569	CcSEcCtD
Etodolac—Anaemia—Methotrexate—stomach cancer	9.61e-05	0.000568	CcSEcCtD
Etodolac—Flushing—Doxorubicin—stomach cancer	9.6e-05	0.000568	CcSEcCtD
Etodolac—Flatulence—Epirubicin—stomach cancer	9.59e-05	0.000567	CcSEcCtD
Etodolac—Tension—Epirubicin—stomach cancer	9.55e-05	0.000565	CcSEcCtD
Etodolac—Dysgeusia—Epirubicin—stomach cancer	9.53e-05	0.000563	CcSEcCtD
Etodolac—Nervousness—Epirubicin—stomach cancer	9.45e-05	0.000559	CcSEcCtD
Etodolac—Feeling abnormal—Capecitabine—stomach cancer	9.39e-05	0.000555	CcSEcCtD
Etodolac—Malaise—Methotrexate—stomach cancer	9.37e-05	0.000554	CcSEcCtD
Etodolac—Vertigo—Methotrexate—stomach cancer	9.34e-05	0.000552	CcSEcCtD
Etodolac—Gastrointestinal pain—Capecitabine—stomach cancer	9.32e-05	0.000551	CcSEcCtD
Etodolac—Body temperature increased—Docetaxel—stomach cancer	9.3e-05	0.00055	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—stomach cancer	9.3e-05	0.00055	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—stomach cancer	9.3e-05	0.00055	CcSEcCtD
Etodolac—Chills—Doxorubicin—stomach cancer	9.28e-05	0.000549	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—stomach cancer	9.24e-05	0.000546	CcSEcCtD
Etodolac—Vision blurred—Epirubicin—stomach cancer	9.17e-05	0.000542	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—stomach cancer	9.14e-05	0.00054	CcSEcCtD
Etodolac—Urticaria—Capecitabine—stomach cancer	9.05e-05	0.000535	CcSEcCtD
Etodolac—Ill-defined disorder—Epirubicin—stomach cancer	9.03e-05	0.000534	CcSEcCtD
Etodolac—Abdominal pain—Capecitabine—stomach cancer	9.01e-05	0.000533	CcSEcCtD
Etodolac—Body temperature increased—Capecitabine—stomach cancer	9.01e-05	0.000533	CcSEcCtD
Etodolac—Convulsion—Methotrexate—stomach cancer	9.01e-05	0.000533	CcSEcCtD
Etodolac—Anaemia—Epirubicin—stomach cancer	8.99e-05	0.000532	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—stomach cancer	8.87e-05	0.000525	CcSEcCtD
Etodolac—Myalgia—Methotrexate—stomach cancer	8.85e-05	0.000523	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—stomach cancer	8.85e-05	0.000523	CcSEcCtD
Etodolac—Tension—Doxorubicin—stomach cancer	8.83e-05	0.000522	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—stomach cancer	8.81e-05	0.000521	CcSEcCtD
Etodolac—Malaise—Epirubicin—stomach cancer	8.77e-05	0.000519	CcSEcCtD
Etodolac—Discomfort—Methotrexate—stomach cancer	8.74e-05	0.000517	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—stomach cancer	8.74e-05	0.000517	CcSEcCtD
Etodolac—Vertigo—Epirubicin—stomach cancer	8.74e-05	0.000517	CcSEcCtD
Etodolac—Syncope—Epirubicin—stomach cancer	8.72e-05	0.000516	CcSEcCtD
Etodolac—Leukopenia—Epirubicin—stomach cancer	8.71e-05	0.000515	CcSEcCtD
Etodolac—Hypersensitivity—Docetaxel—stomach cancer	8.67e-05	0.000513	CcSEcCtD
Etodolac—Palpitations—Epirubicin—stomach cancer	8.6e-05	0.000508	CcSEcCtD
Etodolac—Confusional state—Methotrexate—stomach cancer	8.55e-05	0.000506	CcSEcCtD
Etodolac—Loss of consciousness—Epirubicin—stomach cancer	8.55e-05	0.000506	CcSEcCtD
Etodolac—Anaphylactic shock—Methotrexate—stomach cancer	8.48e-05	0.000502	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—stomach cancer	8.48e-05	0.000502	CcSEcCtD
Etodolac—Asthenia—Docetaxel—stomach cancer	8.44e-05	0.0005	CcSEcCtD
Etodolac—Convulsion—Epirubicin—stomach cancer	8.43e-05	0.000499	CcSEcCtD
Etodolac—Infection—Methotrexate—stomach cancer	8.43e-05	0.000499	CcSEcCtD
Etodolac—Hypertension—Epirubicin—stomach cancer	8.4e-05	0.000497	CcSEcCtD
Etodolac—Hypersensitivity—Capecitabine—stomach cancer	8.4e-05	0.000497	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—stomach cancer	8.35e-05	0.000494	CcSEcCtD
Etodolac—Pruritus—Docetaxel—stomach cancer	8.33e-05	0.000493	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—stomach cancer	8.32e-05	0.000492	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—stomach cancer	8.31e-05	0.000491	CcSEcCtD
Etodolac—Myalgia—Epirubicin—stomach cancer	8.28e-05	0.00049	CcSEcCtD
Etodolac—Arthralgia—Epirubicin—stomach cancer	8.28e-05	0.00049	CcSEcCtD
Etodolac—Anxiety—Epirubicin—stomach cancer	8.25e-05	0.000488	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—stomach cancer	8.2e-05	0.000485	CcSEcCtD
Etodolac—Discomfort—Epirubicin—stomach cancer	8.18e-05	0.000484	CcSEcCtD
Etodolac—Asthenia—Capecitabine—stomach cancer	8.18e-05	0.000484	CcSEcCtD
Etodolac—Malaise—Doxorubicin—stomach cancer	8.12e-05	0.00048	CcSEcCtD
Etodolac—Dry mouth—Epirubicin—stomach cancer	8.1e-05	0.000479	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—stomach cancer	8.09e-05	0.000478	CcSEcCtD
Etodolac—Anorexia—Methotrexate—stomach cancer	8.09e-05	0.000478	CcSEcCtD
Etodolac—Syncope—Doxorubicin—stomach cancer	8.07e-05	0.000477	CcSEcCtD
Etodolac—Pruritus—Capecitabine—stomach cancer	8.06e-05	0.000477	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—stomach cancer	8.06e-05	0.000477	CcSEcCtD
Etodolac—Diarrhoea—Docetaxel—stomach cancer	8.05e-05	0.000476	CcSEcCtD
Etodolac—Confusional state—Epirubicin—stomach cancer	8.01e-05	0.000474	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—stomach cancer	7.95e-05	0.00047	CcSEcCtD
Etodolac—Anaphylactic shock—Epirubicin—stomach cancer	7.94e-05	0.00047	CcSEcCtD
Etodolac—Oedema—Epirubicin—stomach cancer	7.94e-05	0.00047	CcSEcCtD
Etodolac—Hypotension—Methotrexate—stomach cancer	7.93e-05	0.000469	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—stomach cancer	7.91e-05	0.000468	CcSEcCtD
Etodolac—Infection—Epirubicin—stomach cancer	7.89e-05	0.000467	CcSEcCtD
Etodolac—Shock—Epirubicin—stomach cancer	7.81e-05	0.000462	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—stomach cancer	7.8e-05	0.000461	CcSEcCtD
Etodolac—Diarrhoea—Capecitabine—stomach cancer	7.8e-05	0.000461	CcSEcCtD
Etodolac—Dizziness—Docetaxel—stomach cancer	7.78e-05	0.00046	CcSEcCtD
Etodolac—Thrombocytopenia—Epirubicin—stomach cancer	7.77e-05	0.00046	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—stomach cancer	7.77e-05	0.00046	CcSEcCtD
Etodolac—Tachycardia—Epirubicin—stomach cancer	7.75e-05	0.000458	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.73e-05	0.000457	CcSEcCtD
Etodolac—Hyperhidrosis—Epirubicin—stomach cancer	7.67e-05	0.000454	CcSEcCtD
Etodolac—Insomnia—Methotrexate—stomach cancer	7.67e-05	0.000454	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—stomach cancer	7.66e-05	0.000453	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—stomach cancer	7.66e-05	0.000453	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—stomach cancer	7.64e-05	0.000452	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—stomach cancer	7.62e-05	0.000451	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—stomach cancer	7.57e-05	0.000448	CcSEcCtD
Etodolac—Anorexia—Epirubicin—stomach cancer	7.57e-05	0.000448	CcSEcCtD
Etodolac—Dyspnoea—Methotrexate—stomach cancer	7.56e-05	0.000447	CcSEcCtD
Etodolac—Somnolence—Methotrexate—stomach cancer	7.54e-05	0.000446	CcSEcCtD
Etodolac—Dizziness—Capecitabine—stomach cancer	7.54e-05	0.000446	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—stomach cancer	7.49e-05	0.000443	CcSEcCtD
Etodolac—Vomiting—Docetaxel—stomach cancer	7.48e-05	0.000443	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—stomach cancer	7.47e-05	0.000442	CcSEcCtD
Etodolac—Rash—Docetaxel—stomach cancer	7.42e-05	0.000439	CcSEcCtD
Etodolac—Hypotension—Epirubicin—stomach cancer	7.42e-05	0.000439	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—stomach cancer	7.41e-05	0.000439	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—stomach cancer	7.41e-05	0.000438	CcSEcCtD
Etodolac—Decreased appetite—Methotrexate—stomach cancer	7.37e-05	0.000436	CcSEcCtD
Etodolac—Headache—Docetaxel—stomach cancer	7.37e-05	0.000436	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—stomach cancer	7.35e-05	0.000435	CcSEcCtD
Etodolac—Oedema—Doxorubicin—stomach cancer	7.35e-05	0.000435	CcSEcCtD
Etodolac—Fatigue—Methotrexate—stomach cancer	7.31e-05	0.000433	CcSEcCtD
Etodolac—Infection—Doxorubicin—stomach cancer	7.3e-05	0.000432	CcSEcCtD
Etodolac—Pain—Methotrexate—stomach cancer	7.25e-05	0.000429	CcSEcCtD
Etodolac—Vomiting—Capecitabine—stomach cancer	7.25e-05	0.000429	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.23e-05	0.000428	CcSEcCtD
Etodolac—Shock—Doxorubicin—stomach cancer	7.23e-05	0.000427	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—stomach cancer	7.19e-05	0.000425	CcSEcCtD
Etodolac—Rash—Capecitabine—stomach cancer	7.19e-05	0.000425	CcSEcCtD
Etodolac—Insomnia—Epirubicin—stomach cancer	7.18e-05	0.000425	CcSEcCtD
Etodolac—Dermatitis—Capecitabine—stomach cancer	7.18e-05	0.000425	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—stomach cancer	7.17e-05	0.000424	CcSEcCtD
Etodolac—Headache—Capecitabine—stomach cancer	7.14e-05	0.000422	CcSEcCtD
Etodolac—Paraesthesia—Epirubicin—stomach cancer	7.13e-05	0.000422	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—stomach cancer	7.1e-05	0.00042	CcSEcCtD
Etodolac—Dyspnoea—Epirubicin—stomach cancer	7.08e-05	0.000419	CcSEcCtD
Etodolac—Somnolence—Epirubicin—stomach cancer	7.06e-05	0.000417	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—stomach cancer	7e-05	0.000414	CcSEcCtD
Etodolac—Nausea—Docetaxel—stomach cancer	6.99e-05	0.000414	CcSEcCtD
Etodolac—Feeling abnormal—Methotrexate—stomach cancer	6.99e-05	0.000414	CcSEcCtD
Etodolac—Dyspepsia—Epirubicin—stomach cancer	6.99e-05	0.000413	CcSEcCtD
Etodolac—Gastrointestinal pain—Methotrexate—stomach cancer	6.94e-05	0.00041	CcSEcCtD
Etodolac—Decreased appetite—Epirubicin—stomach cancer	6.9e-05	0.000408	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—stomach cancer	6.86e-05	0.000406	CcSEcCtD
Etodolac—Fatigue—Epirubicin—stomach cancer	6.84e-05	0.000405	CcSEcCtD
Etodolac—Pain—Epirubicin—stomach cancer	6.79e-05	0.000402	CcSEcCtD
Etodolac—Constipation—Epirubicin—stomach cancer	6.79e-05	0.000402	CcSEcCtD
Etodolac—Nausea—Capecitabine—stomach cancer	6.77e-05	0.0004	CcSEcCtD
Etodolac—Urticaria—Methotrexate—stomach cancer	6.74e-05	0.000399	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—stomach cancer	6.71e-05	0.000397	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—stomach cancer	6.71e-05	0.000397	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.69e-05	0.000396	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—stomach cancer	6.64e-05	0.000393	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—stomach cancer	6.6e-05	0.00039	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—stomach cancer	6.55e-05	0.000387	CcSEcCtD
Etodolac—Feeling abnormal—Epirubicin—stomach cancer	6.54e-05	0.000387	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—stomach cancer	6.53e-05	0.000386	CcSEcCtD
Etodolac—Gastrointestinal pain—Epirubicin—stomach cancer	6.49e-05	0.000384	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—stomach cancer	6.47e-05	0.000382	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—stomach cancer	6.39e-05	0.000378	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—stomach cancer	6.33e-05	0.000375	CcSEcCtD
Etodolac—Urticaria—Epirubicin—stomach cancer	6.31e-05	0.000373	CcSEcCtD
Etodolac—Pain—Doxorubicin—stomach cancer	6.28e-05	0.000372	CcSEcCtD
Etodolac—Constipation—Doxorubicin—stomach cancer	6.28e-05	0.000372	CcSEcCtD
Etodolac—Abdominal pain—Epirubicin—stomach cancer	6.28e-05	0.000371	CcSEcCtD
Etodolac—Body temperature increased—Epirubicin—stomach cancer	6.28e-05	0.000371	CcSEcCtD
Etodolac—Hypersensitivity—Methotrexate—stomach cancer	6.25e-05	0.00037	CcSEcCtD
Etodolac—Asthenia—Methotrexate—stomach cancer	6.09e-05	0.00036	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—stomach cancer	6.05e-05	0.000358	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—stomach cancer	6.01e-05	0.000355	CcSEcCtD
Etodolac—Pruritus—Methotrexate—stomach cancer	6e-05	0.000355	CcSEcCtD
Etodolac—Hypersensitivity—Epirubicin—stomach cancer	5.85e-05	0.000346	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—stomach cancer	5.84e-05	0.000345	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—stomach cancer	5.81e-05	0.000343	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—stomach cancer	5.81e-05	0.000343	CcSEcCtD
Etodolac—Diarrhoea—Methotrexate—stomach cancer	5.8e-05	0.000343	CcSEcCtD
Etodolac—Asthenia—Epirubicin—stomach cancer	5.7e-05	0.000337	CcSEcCtD
Etodolac—Pruritus—Epirubicin—stomach cancer	5.62e-05	0.000332	CcSEcCtD
Etodolac—Dizziness—Methotrexate—stomach cancer	5.61e-05	0.000332	CcSEcCtD
Etodolac—Diarrhoea—Epirubicin—stomach cancer	5.43e-05	0.000321	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—stomach cancer	5.41e-05	0.00032	CcSEcCtD
Etodolac—Vomiting—Methotrexate—stomach cancer	5.39e-05	0.000319	CcSEcCtD
Etodolac—Rash—Methotrexate—stomach cancer	5.35e-05	0.000316	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—stomach cancer	5.34e-05	0.000316	CcSEcCtD
Etodolac—Headache—Methotrexate—stomach cancer	5.31e-05	0.000314	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—stomach cancer	5.27e-05	0.000312	CcSEcCtD
Etodolac—Dizziness—Epirubicin—stomach cancer	5.25e-05	0.000311	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—stomach cancer	5.2e-05	0.000307	CcSEcCtD
Etodolac—Vomiting—Epirubicin—stomach cancer	5.05e-05	0.000299	CcSEcCtD
Etodolac—Nausea—Methotrexate—stomach cancer	5.04e-05	0.000298	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—stomach cancer	5.03e-05	0.000297	CcSEcCtD
Etodolac—Rash—Epirubicin—stomach cancer	5.01e-05	0.000296	CcSEcCtD
Etodolac—Dermatitis—Epirubicin—stomach cancer	5e-05	0.000296	CcSEcCtD
Etodolac—Headache—Epirubicin—stomach cancer	4.97e-05	0.000294	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—stomach cancer	4.86e-05	0.000287	CcSEcCtD
Etodolac—Nausea—Epirubicin—stomach cancer	4.72e-05	0.000279	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—stomach cancer	4.67e-05	0.000276	CcSEcCtD
Etodolac—Rash—Doxorubicin—stomach cancer	4.63e-05	0.000274	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—stomach cancer	4.63e-05	0.000274	CcSEcCtD
Etodolac—Headache—Doxorubicin—stomach cancer	4.6e-05	0.000272	CcSEcCtD
Etodolac—Nausea—Doxorubicin—stomach cancer	4.36e-05	0.000258	CcSEcCtD
Etodolac—CYP2C9—Metabolism—CKB—stomach cancer	1.5e-05	0.000136	CbGpPWpGaD
Etodolac—ALB—Metabolism—UMPS—stomach cancer	1.5e-05	0.000136	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RORA—stomach cancer	1.5e-05	0.000136	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTP1—stomach cancer	1.5e-05	0.000135	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.48e-05	0.000134	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—HMOX1—stomach cancer	1.47e-05	0.000134	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.47e-05	0.000133	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.46e-05	0.000133	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CD44—stomach cancer	1.46e-05	0.000132	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—stomach cancer	1.43e-05	0.00013	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTT1—stomach cancer	1.43e-05	0.000129	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—MTHFR—stomach cancer	1.43e-05	0.000129	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPP2R1A—stomach cancer	1.42e-05	0.000129	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—stomach cancer	1.42e-05	0.000128	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLIN2—stomach cancer	1.41e-05	0.000128	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.41e-05	0.000128	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP2A6—stomach cancer	1.41e-05	0.000128	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FYN—stomach cancer	1.41e-05	0.000128	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALDOB—stomach cancer	1.4e-05	0.000127	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—stomach cancer	1.4e-05	0.000127	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTP1—stomach cancer	1.39e-05	0.000126	CbGpPWpGaD
Etodolac—ALB—Metabolism—PDHA1—stomach cancer	1.39e-05	0.000126	CbGpPWpGaD
Etodolac—ALB—Metabolism—ECHS1—stomach cancer	1.39e-05	0.000126	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TYMS—stomach cancer	1.39e-05	0.000126	CbGpPWpGaD
Etodolac—RXRA—Metabolism—HMOX1—stomach cancer	1.38e-05	0.000125	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CA2—stomach cancer	1.38e-05	0.000125	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKR1C3—stomach cancer	1.37e-05	0.000124	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTM1—stomach cancer	1.37e-05	0.000124	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK3—stomach cancer	1.35e-05	0.000123	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.35e-05	0.000122	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NT5E—stomach cancer	1.34e-05	0.000121	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PGAM1—stomach cancer	1.34e-05	0.000121	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.34e-05	0.000121	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ENO1—stomach cancer	1.34e-05	0.000121	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.32e-05	0.00012	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.32e-05	0.00012	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CAV1—stomach cancer	1.32e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.32e-05	0.000119	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—APOA1—stomach cancer	1.31e-05	0.000119	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMP—stomach cancer	1.31e-05	0.000119	CbGpPWpGaD
Etodolac—ALB—Metabolism—FADS1—stomach cancer	1.31e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALOX5—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKR1C3—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Disease—RPS19—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TYMS—stomach cancer	1.3e-05	0.000117	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ERCC2—stomach cancer	1.29e-05	0.000117	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK1—stomach cancer	1.29e-05	0.000117	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—stomach cancer	1.29e-05	0.000117	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DPYD—stomach cancer	1.28e-05	0.000116	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTM1—stomach cancer	1.28e-05	0.000116	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.28e-05	0.000116	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLCE1—stomach cancer	1.28e-05	0.000116	CbGpPWpGaD
Etodolac—PTGS2—Disease—ENO1—stomach cancer	1.27e-05	0.000115	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.24e-05	0.000113	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPP2R1A—stomach cancer	1.24e-05	0.000112	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—stomach cancer	1.23e-05	0.000111	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—UMPS—stomach cancer	1.23e-05	0.000111	CbGpPWpGaD
Etodolac—ALB—Metabolism—SREBF2—stomach cancer	1.23e-05	0.000111	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KRAS—stomach cancer	1.22e-05	0.00011	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTP1—stomach cancer	1.21e-05	0.00011	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MTHFR—stomach cancer	1.21e-05	0.00011	CbGpPWpGaD
Etodolac—ALB—Metabolism—RORA—stomach cancer	1.21e-05	0.00011	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ERCC2—stomach cancer	1.2e-05	0.000109	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAU—stomach cancer	1.2e-05	0.000109	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HMOX1—stomach cancer	1.2e-05	0.000109	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CD44—stomach cancer	1.19e-05	0.000108	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PPARG—stomach cancer	1.18e-05	0.000107	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CAV1—stomach cancer	1.18e-05	0.000106	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.18e-05	0.000106	CbGpPWpGaD
Etodolac—ALB—Hemostasis—APOA1—stomach cancer	1.17e-05	0.000106	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.16e-05	0.000105	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PPARG—stomach cancer	1.16e-05	0.000105	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.15e-05	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Disease—RPS6—stomach cancer	1.15e-05	0.000104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ECHS1—stomach cancer	1.14e-05	0.000103	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PDHA1—stomach cancer	1.14e-05	0.000103	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALDOB—stomach cancer	1.13e-05	0.000103	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTT1—stomach cancer	1.13e-05	0.000103	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MTHFR—stomach cancer	1.13e-05	0.000103	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TYMS—stomach cancer	1.13e-05	0.000102	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD44—stomach cancer	1.13e-05	0.000102	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2A6—stomach cancer	1.12e-05	0.000102	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CAV1—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PRKCB—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOA1—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTM1—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKR1C3—stomach cancer	1.09e-05	9.88e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FADS1—stomach cancer	1.07e-05	9.7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMP—stomach cancer	1.07e-05	9.7e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.07e-05	9.69e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.07e-05	9.67e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SERPINE1—stomach cancer	1.06e-05	9.64e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ENO1—stomach cancer	1.06e-05	9.63e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HBEGF—stomach cancer	1.06e-05	9.59e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALOX5—stomach cancer	1.05e-05	9.55e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ERCC2—stomach cancer	1.05e-05	9.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.05e-05	9.47e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CAV1—stomach cancer	1.04e-05	9.46e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOA1—stomach cancer	1.04e-05	9.44e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—stomach cancer	1.04e-05	9.43e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—DPYD—stomach cancer	1.04e-05	9.4e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—stomach cancer	1.03e-05	9.37e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.02e-05	9.19e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPP2R1A—stomach cancer	1.01e-05	9.15e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SREBF2—stomach cancer	1e-05	9.09e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.98e-06	9.04e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—NOS3—stomach cancer	9.96e-06	9.02e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RORA—stomach cancer	9.91e-06	8.98e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTP1—stomach cancer	9.9e-06	8.97e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—stomach cancer	9.9e-06	8.96e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MTHFR—stomach cancer	9.87e-06	8.94e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARG—stomach cancer	9.85e-06	8.92e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HMOX1—stomach cancer	9.77e-06	8.85e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	9.7e-06	8.79e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PPP2R1A—stomach cancer	9.57e-06	8.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CD44—stomach cancer	9.43e-06	8.54e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.41e-06	8.52e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINE1—stomach cancer	9.31e-06	8.43e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALDOB—stomach cancer	9.29e-06	8.41e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TYMS—stomach cancer	9.21e-06	8.34e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARG—stomach cancer	9.18e-06	8.32e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTT1—stomach cancer	9.18e-06	8.31e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—stomach cancer	9.11e-06	8.25e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CAV1—stomach cancer	9.1e-06	8.24e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—stomach cancer	9.1e-06	8.24e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOA1—stomach cancer	9.08e-06	8.22e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2A6—stomach cancer	9.07e-06	8.22e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RHOA—stomach cancer	8.98e-06	8.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SMAD4—stomach cancer	8.89e-06	8.05e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS3—stomach cancer	8.89e-06	8.05e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—stomach cancer	8.85e-06	8.02e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C3—stomach cancer	8.82e-06	7.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.76e-06	7.93e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.74e-06	7.91e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.7e-06	7.88e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALOX5—stomach cancer	8.63e-06	7.82e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ENO1—stomach cancer	8.6e-06	7.79e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ERCC2—stomach cancer	8.56e-06	7.75e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DPYD—stomach cancer	8.49e-06	7.69e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NOS3—stomach cancer	8.47e-06	7.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FYN—stomach cancer	8.44e-06	7.64e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—stomach cancer	8.26e-06	7.48e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERCC2—stomach cancer	8.11e-06	7.35e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTHFR—stomach cancer	8.04e-06	7.29e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPP2R1A—stomach cancer	8.02e-06	7.26e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARG—stomach cancer	8e-06	7.25e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGFR2—stomach cancer	7.92e-06	7.17e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NOS3—stomach cancer	7.9e-06	7.16e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—stomach cancer	7.86e-06	7.12e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HMOX1—stomach cancer	7.75e-06	7.02e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—stomach cancer	7.75e-06	7.02e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.7e-06	6.97e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CD44—stomach cancer	7.63e-06	6.91e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTHFR—stomach cancer	7.62e-06	6.91e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTT1—stomach cancer	7.51e-06	6.8e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2A6—stomach cancer	7.43e-06	6.73e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAV1—stomach cancer	7.42e-06	6.72e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOA1—stomach cancer	7.4e-06	6.7e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.4e-06	6.7e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TYMS—stomach cancer	7.31e-06	6.62e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS2—stomach cancer	7.25e-06	6.57e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—stomach cancer	7.23e-06	6.54e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—stomach cancer	7.23e-06	6.54e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C3—stomach cancer	7.22e-06	6.54e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—stomach cancer	7.19e-06	6.52e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.09e-06	6.42e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ENO1—stomach cancer	7.04e-06	6.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CAV1—stomach cancer	7.03e-06	6.37e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOA1—stomach cancer	7.02e-06	6.36e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MAPK3—stomach cancer	6.92e-06	6.27e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.92e-06	6.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NOS3—stomach cancer	6.88e-06	6.23e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ERCC2—stomach cancer	6.79e-06	6.15e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—stomach cancer	6.73e-06	6.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6ST—stomach cancer	6.67e-06	6.04e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARG—stomach cancer	6.52e-06	5.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPP2R1A—stomach cancer	6.49e-06	5.87e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—stomach cancer	6.41e-06	5.8e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—stomach cancer	6.4e-06	5.8e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTHFR—stomach cancer	6.39e-06	5.78e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—stomach cancer	6.36e-06	5.76e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—stomach cancer	6.29e-06	5.7e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—HMOX1—stomach cancer	6.27e-06	5.68e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CD44—stomach cancer	6.24e-06	5.65e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.06e-06	5.49e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK3—stomach cancer	6.06e-06	5.49e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6R—stomach cancer	5.95e-06	5.39e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMS—stomach cancer	5.91e-06	5.36e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAV1—stomach cancer	5.89e-06	5.33e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOA1—stomach cancer	5.88e-06	5.32e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—stomach cancer	5.87e-06	5.31e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—stomach cancer	5.85e-06	5.29e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK1—stomach cancer	5.76e-06	5.22e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.63e-06	5.1e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NOS3—stomach cancer	5.61e-06	5.08e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—stomach cancer	5.6e-06	5.08e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SERPINE1—stomach cancer	5.57e-06	5.05e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ERCC2—stomach cancer	5.5e-06	4.98e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—stomach cancer	5.44e-06	4.93e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—RHOA—stomach cancer	5.37e-06	4.87e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS3—stomach cancer	5.32e-06	4.82e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.31e-06	4.81e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—stomach cancer	5.21e-06	4.72e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARG—stomach cancer	5.18e-06	4.69e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTHFR—stomach cancer	5.17e-06	4.68e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HMOX1—stomach cancer	5.14e-06	4.65e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—stomach cancer	5.13e-06	4.65e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—stomach cancer	5e-06	4.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—stomach cancer	4.97e-06	4.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMS—stomach cancer	4.84e-06	4.38e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—stomach cancer	4.84e-06	4.38e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—stomach cancer	4.78e-06	4.33e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—stomach cancer	4.77e-06	4.32e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAV1—stomach cancer	4.77e-06	4.32e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOA1—stomach cancer	4.75e-06	4.31e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—stomach cancer	4.66e-06	4.22e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—stomach cancer	4.63e-06	4.19e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1B—stomach cancer	4.61e-06	4.17e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.55e-06	4.12e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ERCC2—stomach cancer	4.5e-06	4.07e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NOS3—stomach cancer	4.45e-06	4.03e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—stomach cancer	4.45e-06	4.03e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1A—stomach cancer	4.25e-06	3.85e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTHFR—stomach cancer	4.23e-06	3.83e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARG—stomach cancer	4.19e-06	3.79e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAV1—stomach cancer	3.9e-06	3.53e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOA1—stomach cancer	3.89e-06	3.52e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—stomach cancer	3.87e-06	3.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—stomach cancer	3.79e-06	3.44e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.73e-06	3.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK3—stomach cancer	3.62e-06	3.28e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NOS3—stomach cancer	3.6e-06	3.26e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—stomach cancer	3.53e-06	3.19e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK1—stomach cancer	3.45e-06	3.12e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—stomach cancer	3.45e-06	3.12e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARG—stomach cancer	3.43e-06	3.11e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—stomach cancer	3.3e-06	2.98e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—stomach cancer	3.26e-06	2.95e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—stomach cancer	3.16e-06	2.86e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—stomach cancer	3.08e-06	2.79e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—stomach cancer	2.99e-06	2.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NOS3—stomach cancer	2.95e-06	2.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—stomach cancer	2.77e-06	2.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—stomach cancer	2.7e-06	2.44e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—stomach cancer	2.65e-06	2.4e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—stomach cancer	2.51e-06	2.27e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—stomach cancer	2.03e-06	1.84e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.66e-06	1.5e-05	CbGpPWpGaD
